Idiopathic Urticaria
📧 Sign up to get email alerts when something new happens for Idiopathic Urticaria.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2012-11-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approved a supplemental application for Levocetirizine Dihydrochloride from Camber Pharmaceuticals, Inc.
-
FDA approval · 2012-11-20FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc. The approval updates the d…
-
FDA approval · 2012-11-16FDA Approved: CLARITIN — Supplemental Application (Bayer HealthCare LLC)
The FDA approved a supplemental application for Claritin (loratadine) submitted by Bayer HealthCare LLC.
-
CLINICAL_TRIALS research · 2012-11-06Clinical Trial Update: T Cell Function in Chronic Idiopathic Urticaria
A clinical trial update focusing on T cell function in chronic idiopathic urticaria.
-
FDA approval · 2012-06-29FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)
FDA approved Camber Pharmaceuticals' original application for levocetirizine dihydrochloride, a generic antihistamine. It is indicated for a…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2012-05-11FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals Labs Inc.)
The FDA approved the original ANDA for cetirizine hydrochloride (oral solution) from Heritage Pharma Labs Inc. d/b/a Avet Pharmaceuticals La…
-
FDA approval · 2012-04-19FDA Approved: DESLORATADINE — Original Application (Virtus Pharmaceuticals, LLC)
The FDA approved Virtus Pharmaceuticals, LLC’s generic desloratadine via an Original Application (ANDA). This adds a generic option for desl…
-
CLINICAL_TRIALS trial_result · 2012-04-05Clinical Trial Update: Efficacy Study for the Symptomatic Treatment of Chronic Idiopathic Urticaria [Phase 3]
A Phase 3 efficacy trial evaluating symptomatic treatment for chronic idiopathic urticaria has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-16Clinical Trial Update: The Efficacy of a Pseudoallergen-Free Diet in the Treatment of Chronic Idiopathic Urticaria and/or Angioedema [NA]
This entry reports an update on a clinical trial evaluating whether a pseudoallergen-free diet can treat chronic idiopathic urticaria and/or…
-
FDA approval · 2012-02-10FDA Approved: DESLORATADINE — Original Application (Natco Pharma USA LLC)
FDA approved an original application for a desloratadine generic from Natco Pharma USA LLC.
-
FDA approval · 2011-11-18FDA Approved: DESLORATADINE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for desloratadine submitted by Dr. Reddy's Laboratories Limited, marking an approval of changes …
-
FDA approval · 2011-11-07FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Padagis Israel Pharmaceuticals Ltd)
FDA approves the original application for levocetirizine dihydrochloride from Padagis Israel Pharmaceuticals Ltd, a generic antihistamine.
-
FDA approval · 2011-09-23FDA Approved: FEXOFENADINE HYDROCHLORIDE — Supplemental Application (Dr. Reddy's Laboratories Limited)
The FDA approved a supplemental application for fexofenadine hydrochloride from Dr. Reddy's Laboratories Limited, enabling the generic produ…
-
CLINICAL_TRIALS trial_result · 2011-09-09Clinical Trial Update: A Study of Xolair (Omalizumab) in Patients With Chronic Idiopathic Urticaria (CIU) Who Remain Symptomatic With Antihistamine Treatment (H1) [Phase 2]
Phase 2 trial update of omalizumab (Xolair) in patients with chronic idiopathic urticaria who remain symptomatic despite antihistamines; the…
-
FDA approval · 2011-03-07FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
The FDA approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc.
-
FDA approval · 2011-02-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Dr.Reddy's laboratories Ltd.)
FDA approved Dr. Reddy's Laboratories' original application for levocetirizine dihydrochloride, a generic antihistamine. The approval covers…
-
FDA approval · 2011-02-24FDA Approved: LEVOCETIRIZINE DIHYDROCHLORIDE — Original Application (Glenmark Pharmaceuticals Inc., USA)
FDA approved Glenmark's original application for levocetirizine dihydrochloride, a generic antihistamine.
-
FDA approval · 2010-10-25FDA Approved: DESLORATADINE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' original ANDA for desloratadine, a non-sedating antihistamine used to treat allergic rhinitis and urtica…
-
FDA approval · 2010-07-12FDA Approved: DESLORATADINE — Original Application (Dr. Reddy's Laboratories Limited)
FDA approved Desloratadine from Dr. Reddy's Laboratories Limited as an original ANDA, making a generic desloratadine available for use in al…
-
CLINICAL_TRIALS trial_result · 2010-05-03Clinical Trial Update: Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849) [Phase 4]
Phase 4 clinical trial update evaluating high-dose desloratadine (AERIUS) for chronic idiopathic urticaria; results have been posted.
-
CLINICAL_TRIALS trial_result · 2010-03-24Clinical Trial Update: Autologous Serum Skin Test and Serum IL-18 Levels in Chronic Idiopathic Urticaria and Respiratory Allergic Diseases
A completed clinical trial evaluating autologous serum skin tests and serum IL-18 levels in chronic idiopathic urticaria and respiratory all…
-
FDA label_change · 2010-03-10FDA Approved: COUNTERACT ALLERGY — Supplemental Application (Melaleuca, Inc.)
The FDA approved Melaleuca, Inc.'s supplemental application for COUNTERACT ALLERGY (loratadine), resulting in a labeling update for the prod…
-
FDA approval · 2010-02-19FDA Approved: DESLORATADINE — Original Application (Bionpharma Inc.)
FDA approved the original ANDA for desloratadine from Bionpharma Inc., a generic antihistamine. The approval is for the treatment of allergi…
-
FDA approval · 2009-10-07FDA Approved: CETIRIZINE HYDROCHLORIDE — Original Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals' cetirizine hydrochloride as an Original Application (ANDA090765), establishing a generic cetirizine pro…
-
FDA approval · 2009-08-21FDA Approved: XYZAL — Supplemental Application (Chattem, Inc.)
FDA has approved a supplemental application for XYZAL (levocetirizine dihydrochloride) submitted by Chattem, Inc., effectively granting appr…